Lab-on-a-chip for the easy and visual detection of SARS-CoV-2 in saliva based on sensory polymers
- PMID: 36536612
- PMCID: PMC9751010
- DOI: 10.1016/j.snb.2022.133165
Lab-on-a-chip for the easy and visual detection of SARS-CoV-2 in saliva based on sensory polymers
Abstract
The initial stages of the pandemic caused by SARS-CoV-2 showed that early detection of the virus in a simple way is the best tool until the development of vaccines. Many different tests are invasive or need the patient to cough up or even drag a sample of mucus from the throat area. Besides, the manufacturing time has proven insufficient in pandemic conditions since they were out of stock in many countries. Here we show a new method of manufacturing virus sensors and a proof of concept with SARS-CoV-2. We found that a fluorogenic peptide substrate of the main protease of the virus (Mpro) can be covalently immobilized in a polymer, with which a cellulose-based material can be coated. These sensory labels fluoresce with a single saliva sample of a positive COVID-19 patient. The results matched with that of the antigen tests in 22 of 26 studied cases (85% success rate).
Keywords: COVID-19; Coating; Fluorimetry; Immobilization; Pandemics; Paper-supported; Peptide; Substrate.
© 2022 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures





Similar articles
-
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z. Trials. 2021. PMID: 33419461 Free PMC article.
-
Diagnostic Performance of Self-Collected Saliva Versus Nasopharyngeal Swab for the Molecular Detection of SARS-CoV-2 in the Clinical Setting.Microbiol Spectr. 2021 Dec 22;9(3):e0046821. doi: 10.1128/Spectrum.00468-21. Epub 2021 Nov 3. Microbiol Spectr. 2021. PMID: 34730436 Free PMC article.
-
SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19-Seropositive Individuals.J Immunol. 2020 Dec 1;205(11):3130-3140. doi: 10.4049/jimmunol.2000842. Epub 2020 Nov 4. J Immunol. 2020. PMID: 33148714 Clinical Trial.
-
Discovery of a "Cocktail" of Potential SARS-COV-2 Main Protease Inhibitors through Virtual Screening of Known Chemical Components of Vitex negundo L. ("Lagundi").Med Chem. 2022;18(3):364-381. doi: 10.2174/1573406417666210618132003. Med Chem. 2022. PMID: 34148541
-
Saliva as a sample type for SARS-CoV-2 detection: implementation successes and opportunities around the globe.Expert Rev Mol Diagn. 2022 May;22(5):519-535. doi: 10.1080/14737159.2022.2094250. Epub 2022 Jul 4. Expert Rev Mol Diagn. 2022. PMID: 35763281 Review.
Cited by
-
Sensory Polymers: Trends, Challenges, and Prospects Ahead.Sensors (Basel). 2024 Jun 14;24(12):3852. doi: 10.3390/s24123852. Sensors (Basel). 2024. PMID: 38931634 Free PMC article. Review.
References
-
- University of Oxford, COVID-19 Data Explorer, (2022). 〈https://ourworldindata.org/explorers/coronavirus-data-explorer〉 (Accessed March 7, 2022).
-
- Hale T., Angrist N., Goldszmidt R., Kira B., Petherick A., Phillips T., Webster S., Cameron-Blake E., Hallas L., Majumdar S., Tatlow H. A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker) Nat. Hum. Behav. 2021;5:529–538. doi: 10.1038/S41562-021-01079-8. - DOI - PubMed
-
- Artik Y., Kurtulmus M.S., Cesur N.P., Mart Komurcu S.Z., Kazezoglu C., Kocatas A. Clinic evaluation of the destrovir spray effectiveness in SARS-CoV-2 disease. Electron. J. Gen. Med. 2022;19:em357. doi: 10.29333/EJGM/11578. - DOI
-
- Fernandes Q., Inchakalody V.P., Merhi M., Mestiri S., Taib N., Moustafa Abo El-Ella D., Bedhiafi T., Raza A., Al-Zaidan L., Mohsen M.O., Yousuf Al-Nesf M.A., Hssain A.A., Yassine H.M., Bachmann M.F., Uddin S., Dermime S. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines. Ann. Med. 2022;54:524–540. doi: 10.1080/07853890.2022.2031274. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous